Smigrodzki Rafal, Parks Janice, Parker W Davis
Department of Neurology, University of Virginia, BNG1370, Research Lane, Charlottesville, VA 22908, USA.
Neurobiol Aging. 2004 Nov-Dec;25(10):1273-81. doi: 10.1016/j.neurobiolaging.2004.02.020.
Idiopathic Parkinson's disease (PD) involves a systemic loss of activity of complex I of the mitochondrial electron transport chain. This biochemical lesion plays a key pathogenic role. Transfer of PD mitochondrial DNA recapitulates this loss of activity and several other pathogenic features of PD suggesting that this lesion may arise, at least in part, from mitochondrial DNA. We investigated this possibility by an extensive clonal sequencing of the seven mitochondrial genes encoding complex I subunits in PD and age-matched control frontal cortex. Each gene was completely sequenced an average of 94.4 times for each subject. Aminoacid-changing mutations were found at the frequency of 59.3 per million bases in both PD and controls, corresponding to approximately 32% of the mitochondrial genomes in the average sample having at least one mutation in a complex I gene. Individual low frequency mutations had an abundance of 1-10%. Significant interindividual variation in mutation frequency was observed. Several aminoacid-changing mutations were identified and multiple PD brains but not in controls. Genetic algorithm analysis detected areas in ND genes with a higher mutation frequency in PD that allowed differentiation of PD from controls. Total mutational burden due to low-abundance heteroplasmy is high and may play a role in human disease.
特发性帕金森病(PD)涉及线粒体电子传递链复合体I的系统性活性丧失。这种生化损伤起着关键的致病作用。PD线粒体DNA的转移重现了这种活性丧失以及PD的其他一些致病特征,这表明这种损伤可能至少部分源于线粒体DNA。我们通过对PD患者和年龄匹配的对照额叶皮质中编码复合体I亚基的七个线粒体基因进行广泛的克隆测序来研究这种可能性。每个基因对每个受试者平均完全测序94.4次。在PD患者和对照中,氨基酸改变突变的频率均为每百万碱基59.3次,这相当于平均样本中线粒体基因组的约32%在复合体I基因中至少有一个突变。个体低频突变的丰度为1%-10%。观察到突变频率存在显著的个体间差异。在多个PD脑样本中鉴定出了几个氨基酸改变突变,但在对照中未发现。遗传算法分析检测到ND基因中PD患者突变频率较高的区域,这使得能够区分PD患者和对照。低丰度异质性导致的总突变负荷很高,可能在人类疾病中起作用。